PAA10 BUDGET IMPACT ANALYSIS: COMBINATION FLUTICASONE AND SALMETEROL FOR ASTHMA
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
OBJECTIVE To assess the incremental cost-effectiveness of inhaled medication use in chronic obstructive pulmonary disease (COPD). STUDY DESIGN A Markov model was constructed to estimate the incremental quality-adjusted life-years (QALYs) gained of the alternative treatment arms used in the Towards a Revolution in COPD Health (TORCH) study (ie, salmeterol-fluticasone propionate combination [SF...
متن کاملCombination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
BACKGROUND Long-acting beta-agonists are a common second line treatment in people with asthma inadequately controlled with inhaled corticosteroids. Single device inhalers combine a long-acting beta-agonist with an inhaled steroid delivering both drugs as a maintenance treatment regimen. This updated review compares two fixed-dose options, fluticasone/salmeterol FP/SALand budesonide/formoterol, ...
متن کاملEvaluation of Fluticasone Propionate and Fluticasone Propionate/Salmeterol Combination on Exercise in Pediatric and Adolescent Patients with Asthma
OBJECTIVE This study was designed to demonstrate that four weeks of fluticasone propionate (FP) 100 micrograms (mcg) combined with salmeterol 50 mcg twice daily (BID) via DISKUS(®) resulted in protection against bronchospasm induced by activity, as measured by standardized exercise challenge testing in pediatric and adolescent subjects who required regular use of inhaled corticosteroids for the...
متن کاملInhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
UNLABELLED The long-acting beta2-agonist salmeterol and the corticosteroid fluticasone propionate are available as a combination inhalation device for the treatment of persistent asthma. Well designed studies in adults, adolescents and children aged > or =4 years, demonstrate that combined salmetero/fluticasone propionate 50/100, 50/250 and 50/500 microg administered via a dry powder inhaler (D...
متن کاملFluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
OBJECTIVES To compare the efficacies of medium-dose fluticasone propionate (FP), medium-dose triamcinolone acetonide (TAA), and combined low-dose FP plus salmeterol (SL). DESIGN Randomized, double-blind, triple-dummy, multicenter, 12-week clinical trial. SETTING Allergy/respiratory care clinics. PATIENTS Six hundred eighty patients with asthma previously uncontrolled with low-dose inhaled...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2004
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62351-0